Johnson & Johnson (JNJ) Tax Provisions (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Tax Provisions came in at $755.0 million in Q1 2026, down 71.31% year-on-year from $2.6 billion in Q1 2025, and up 603.33% quarter-over-quarter from -$150.0 million in Q4 2025.

Johnson & Johnson (JNJ) Tax Provisions (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Tax Provisions across 18 years of filings, most recently posting $755.0 million for Q1 2026.

  • Tax Provisions for Q1 2026 came in at $755.0 million, down 71.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 billion (down 18.65% YoY), and the FY2025 annual result was $5.8 billion, up 120.41% from the prior year.
  • Tax Provisions came in at $755.0 million for Q1 2026 at Johnson & Johnson, up from -$150.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.6 billion in Q1 2025 to a low of -$796.0 million in Q2 2023.
  • The 5-year median for Tax Provisions is $862.0 million (2022), against an average of $863.6 million.
  • Across the five-year window, Tax Provisions tumbled 211.64% in 2023 and surged 473.42% in 2025, its largest moves.
  • Johnson & Johnson's Tax Provisions stood at $862.0 million in 2022, then slipped by 19.49% to $694.0 million in 2023, then slumped by 34.29% to $456.0 million in 2024, then sank by 132.89% to -$150.0 million in 2025, then soared by 603.33% to $755.0 million in 2026.
  • The last three Tax Provisions figures came in at $755.0 million (Q1 2026), -$150.0 million (Q4 2025), and $2.3 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -411.19 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 1.45 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 755.00 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 342.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 709.00 Mn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 265.00 Mn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 559.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 461.00 Mn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 561.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 755.00 Mn
Dec 28, 2025 -150.00 Mn
Sep 28, 2025 2.34 Bn
Jun 29, 2025 954.00 Mn
Mar 30, 2025 2.63 Bn
Dec 29, 2024 456.00 Mn
Sep 29, 2024 644.00 Mn
Jun 30, 2024 1.06 Bn
Mar 31, 2024 459.00 Mn
Dec 31, 2023 694.00 Mn
Oct 1, 2023 908.00 Mn
Jul 2, 2023 930.00 Mn
Apr 2, 2023 -796.00 Mn
Jan 1, 2023 1.19 Bn
Oct 2, 2022 862.00 Mn
Jul 3, 2022 1.03 Bn
Apr 3, 2022 713.00 Mn
Oct 3, 2021 182.00 Mn
Jul 4, 2021 384.00 Mn
Apr 4, 2021 1.23 Bn